Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]
Long-term extension Phase 3 trial of ustekinumab in pediatric patients is being conducted for Crohn's disease and ulcerative colitis, with a…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
Clinical trial update indicating a completed study evaluating infections in adults with Ulcerative Colitis or Crohn's Disease.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Transfer of Feces in Ulcerative Colitis 2 [Phase 2]
A Phase 2 clinical trial evaluating transfer of feces (fecal microbiota transplantation) for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis
A completed clinical trial evaluating the effectiveness and safety of Upadacitinib for acute severe ulcerative colitis reports results on it…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 2]
Phase 2 pediatric trial evaluating the long-term safety of intravenous vedolizumab in children with ulcerative colitis or Crohn's disease; r…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: The Role of Secondary Bile Acids in Intestinal Inflammation [Phase 2, Phase 3]
A Stanford-sponsored Phase 2/Phase 3 trial evaluating secondary bile acids for intestinal inflammation in ulcerative colitis and pouchitis h…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: TUDCA as a Therapy for Ulcerative Colitis (UC) [Phase 1]
A Phase 1 clinical trial evaluating tauroursodeoxycholic acid (TUDCA) for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) [NA]
A completed clinical trial comparing high-definition colonoscopy to dye-sprayed chromo-colonoscopy for colorectal cancer screening in patien…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Rehabilitation After Ileo-anal Pouch Surgery [NA]
A completed clinical trial update on rehabilitation after ileo-anal pouch surgery, examining physical therapy modalities and biofeedback.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Impact of the Novel UC-TREAT Diet on the Gut Microbiome and Its Acceptability in Healthy Adults and Adults With Quiescent Ulcerative Colitis [NA]
The UC-TREAT diet trial evaluated its effects on the gut microbiome and acceptance in healthy adults and adults with quiescent ulcerative co…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA
Takeda is providing expanded access to vedolizumab for children and teenagers with Crohn's disease or ulcerative colitis in the United State…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects
This completed clinical trial evaluated the pharmacokinetics of ozanimod and its major metabolites in healthy subjects to characterize expos…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis [Phase 1]
Phase 1 study to assess safety, pharmacokinetics, and effects of PF-07054894 in ulcerative colitis; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) [Phase 2]
A Phase 2 trial of vixarelimab for moderate-to-severe ulcerative colitis was terminated, with the study results posted on February 24, 2026.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease [Phase 1]
Phase 1 study of PALI-2108 in healthy volunteers and patients with ulcerative colitis or fibrostenosing Crohn's disease is active but not re…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1]
A Phase 1b trial evaluating the safety of MB310 in patients with active, mild-to-moderate ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) [NA]
The PRInCE-UC clinical trial evaluating prebiotics to reduce inflammation and improve clinical endpoints in ulcerative colitis has completed…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice [Phase 4]
An open-label Phase 4 study of Ozanimod in moderate-to-severe ulcerative colitis was terminated, with results posted in February 2026.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis [Phase 4]
This Phase 4 trial update investigates whether interleukin-7 receptor gene polymorphism is associated with ulcerative colitis risk. The stud…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating SHR-1139 for efficacy, safety, and pharmacokinetics in adults with moderately to severely active ulcerativ…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU [NA]
A completed clinical trial evaluating telemonitoring in the management of complex inflammatory bowel disease (Crohn's disease and ulcerative…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: R-3750 in Patients With Mild to Moderate Ulcerative Colitis [Phase 1]
Phase 1 clinical trial update for R-3750 in adults with Ulcerative colitis is currently recruiting, sponsored by Rise Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients [Phase 2]
A Phase 2 trial investigating whether rutin modulates inflammation pathways in patients with ulcerative colitis has completed. The update no…